Horizon Therapeutics PLC (NASDAQ:HZNP)

91.09
Delayed Data
As of Jan 14
 +0.70 / +0.77%
Today’s Change
70.15
Today|||52-Week Range
120.54
-15.47%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 140.00, with a high estimate of 155.00 and a low estimate of 131.00. The median estimate represents a +53.69% increase from the last price of 91.09.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.38
Sales
$995.7M
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.97%
 
 
 
 
 
 
Growthannually 21.61%
 
 
 
 
 
 

Sales

Growthquarterly -3.99%
 
 
 
 
 
 
Growthannually 45.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.